Skip to Content


June 2, 2016

Checkpoint Inhibitors remove negative regulators (“brakes”) on T cells, allowing T cells to attack the tumor.

Tumor vaccines expose the immune system to cancer antigens to produce an immune response.

T cell therapies entail removing T cells from the body then engineering them to recognize cancer cells.

– Source Douglas B. Johnson, M.D.